<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"
        xmlns:video="http://www.google.com/schemas/sitemap-video/1.1"
        xmlns:xhtml="http://www.w3.org/1999/xhtml">
  <url>
    <loc>https://global.investnews.co.kr/news/monster-riot-investment-webtoon-ip-expansion</loc>
    <lastmod>2026-10-16T14:02:07+09:00</lastmod>
    <xhtml:link rel="alternate" hreflang="en" href="https://global.investnews.co.kr/news/monster-riot-investment-webtoon-ip-expansion"/>
    <xhtml:link rel="alternate" hreflang="ja" href="https://global.investnews.co.kr/ja/news/monster-riot-investment-webtoon-ip-expansion"/>
    <xhtml:link rel="alternate" hreflang="vi" href="https://global.investnews.co.kr/vi/news/monster-riot-investment-webtoon-ip-expansion"/>
    <xhtml:link rel="alternate" hreflang="zh" href="https://global.investnews.co.kr/zh/news/monster-riot-investment-webtoon-ip-expansion"/>
    <xhtml:link rel="alternate" hreflang="x-default" href="https://global.investnews.co.kr/news/monster-riot-investment-webtoon-ip-expansion"/>
    <news:news>
      <news:publication>
        <news:name>INVEST NEWS</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-16T14:02:07+09:00</news:publication_date>
      <news:title><![CDATA[[Series] Monster Riot, Webtoon Studio Led by 'Terror Man' Creator, Raises 700 Million Won... Aiming for 100 IPs Within 3 Years]]></news:title>
      <news:keywords><![CDATA[Monster Riot, Ko Jin-ho, Terror Man, Union Investment Partners, webtoon, IP, Series Ventures]]></news:keywords>
    </news:news>
    <image:image>
      <image:loc>https://global.investnews.co.kr/storage/investnews-global/2026/10/7080da46-535a-4de4-b7e1-8d5ac6b993c6-6ac8deff-og16x9.webp</image:loc>
      <image:caption><![CDATA[Action-fantasy webtoon production company Monster Riot has secured 700 million won in investment from Union Investment Partners. The company aims to accumulate 100 original IPs within three years and achieve profitability by 2028.]]></image:caption>
      <image:title><![CDATA[[Series] Monster Riot, Webtoon Studio Led by 'Terror Man' Creator, Raises 700 Million Won... Aiming for 100 IPs Within 3 Years]]></image:title>
    </image:image>
  </url>
  <url>
    <loc>https://global.investnews.co.kr/news/animal-testing-alternatives-investors</loc>
    <lastmod>2026-10-15T18:45:03+09:00</lastmod>
    <xhtml:link rel="alternate" hreflang="en" href="https://global.investnews.co.kr/news/animal-testing-alternatives-investors"/>
    <xhtml:link rel="alternate" hreflang="ja" href="https://global.investnews.co.kr/ja/news/animal-testing-alternatives-investors"/>
    <xhtml:link rel="alternate" hreflang="vi" href="https://global.investnews.co.kr/vi/news/animal-testing-alternatives-investors"/>
    <xhtml:link rel="alternate" hreflang="zh" href="https://global.investnews.co.kr/zh/news/animal-testing-alternatives-investors"/>
    <xhtml:link rel="alternate" hreflang="x-default" href="https://global.investnews.co.kr/news/animal-testing-alternatives-investors"/>
    <news:news>
      <news:publication>
        <news:name>INVEST NEWS</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-15T18:45:03+09:00</news:publication_date>
      <news:title><![CDATA[What Investors Should Look for in Animal Testing Alternatives]]></news:title>
      <news:keywords><![CDATA[NAMs, OrganoPlus, J&P Medi Partners, VILLIORGAN™, CANORGAN™, MAXORGAN™, TIPS]]></news:keywords>
    </news:news>
    <image:image>
      <image:loc>https://global.investnews.co.kr/storage/investnews-global/2026/10/6b9cf325-ac32-47b7-8eee-b8b3ed6e232b-9df219a7-og16x9.webp</image:loc>
      <image:caption><![CDATA[J&P Medi Partners says investors should assess whether NAMs provide useful information for development decisions, meet customer needs and can support repeatable services. Its portfolio company OrganoPlus is developing human-based nonclinical validation platforms and plans to build a data production system.]]></image:caption>
      <image:title><![CDATA[What Investors Should Look for in Animal Testing Alternatives]]></image:title>
    </image:image>
  </url>
  <url>
    <loc>https://global.investnews.co.kr/news/nvidia-apac-ai-startups</loc>
    <lastmod>2026-10-15T18:40:27+09:00</lastmod>
    <xhtml:link rel="alternate" hreflang="en" href="https://global.investnews.co.kr/news/nvidia-apac-ai-startups"/>
    <xhtml:link rel="alternate" hreflang="ja" href="https://global.investnews.co.kr/ja/news/nvidia-apac-ai-startups"/>
    <xhtml:link rel="alternate" hreflang="vi" href="https://global.investnews.co.kr/vi/news/nvidia-apac-ai-startups"/>
    <xhtml:link rel="alternate" hreflang="zh" href="https://global.investnews.co.kr/zh/news/nvidia-apac-ai-startups"/>
    <xhtml:link rel="alternate" hreflang="x-default" href="https://global.investnews.co.kr/news/nvidia-apac-ai-startups"/>
    <news:news>
      <news:publication>
        <news:name>INVEST NEWS</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-15T18:40:27+09:00</news:publication_date>
      <news:title><![CDATA[Five South Korean Startups Named to NVIDIA Inception Grand Challenge 2026 Asia-Pacific Top 10]]></news:title>
      <news:keywords><![CDATA[NVIDIA Inception Grand Challenge 2026, South Korean startups, AI security, industrial AI, live-stream advertising, robotics, Singapore]]></news:keywords>
    </news:news>
    <image:image>
      <image:loc>https://global.investnews.co.kr/storage/investnews-global/2026/10/e52e9276-d766-4d59-9942-eb4774d80697-aca8a5e1-og16x9.webp</image:loc>
      <image:caption><![CDATA[AIM Intelligence, Tnaps, Omelet, Filer and WIM said they were selected for the NVIDIA Inception Grand Challenge 2026 Asia-Pacific final top 10, held in Singapore on September 22. The startups presented work in AI security, industrial decision-making, live-stream ad suitability and robot control.]]></image:caption>
      <image:title><![CDATA[Five South Korean Startups Named to NVIDIA Inception Grand Challenge 2026 Asia-Pacific Top 10]]></image:title>
    </image:image>
  </url>
  <url>
    <loc>https://global.investnews.co.kr/news/osong-lanzhou-bioindustry-cooperation</loc>
    <lastmod>2026-10-15T18:09:19+09:00</lastmod>
    <xhtml:link rel="alternate" hreflang="en" href="https://global.investnews.co.kr/news/osong-lanzhou-bioindustry-cooperation"/>
    <xhtml:link rel="alternate" hreflang="ja" href="https://global.investnews.co.kr/ja/news/osong-lanzhou-bioindustry-cooperation"/>
    <xhtml:link rel="alternate" hreflang="vi" href="https://global.investnews.co.kr/vi/news/osong-lanzhou-bioindustry-cooperation"/>
    <xhtml:link rel="alternate" hreflang="zh" href="https://global.investnews.co.kr/zh/news/osong-lanzhou-bioindustry-cooperation"/>
    <xhtml:link rel="alternate" hreflang="x-default" href="https://global.investnews.co.kr/news/osong-lanzhou-bioindustry-cooperation"/>
    <news:news>
      <news:publication>
        <news:name>INVEST NEWS</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-15T18:09:19+09:00</news:publication_date>
      <news:title><![CDATA[Proposal Links Osong and Lanzhou to Support Korea-China Bioindustry Cooperation]]></news:title>
      <news:keywords><![CDATA[Osong, Lanzhou, Korea-China cooperation, bioindustry, market entry, regulatory support, joint clinical trials]]></news:keywords>
    </news:news>
    <image:image>
      <image:loc>https://global.investnews.co.kr/storage/investnews-global/2026/10/4315cf16-d1f5-45be-ac3f-41c6dea5f03b-2540831a-og16x9.webp</image:loc>
      <image:caption><![CDATA[A proposal at a National Assembly of the Republic of Korea forum called for linking bioindustry hubs in Osong and Lanzhou to help companies with facilities, research support, regulatory information and local partners. Speakers also urged phased cooperation, starting with focused projects such as technology transfer, regulatory information exchange and joint clinical trials in rare diseases and pediatrics.]]></image:caption>
      <image:title><![CDATA[Proposal Links Osong and Lanzhou to Support Korea-China Bioindustry Cooperation]]></image:title>
    </image:image>
  </url>
</urlset>
